Angle Share News (AGL)

ANGLE Gets Positive Results From Parsortix System Trials

LONDON (Alliance News) - ANGLE PLC on Thursday said its Parsortix system has developed an optimised workflow for the recovery and culturing of circulating tumour cells.Parsortix allows this

Australia shares ease for 4th day as financials drag; NZ higher

* ANZ falls for the eighth straight day * Fonterra slightly lower after NZ milk production falls in Feb By Susan Mathew April 4 (Reuters) - Australian shares eased for a day a

UPDATE 1-Australia's AGL says approached by Alinta to buy coal-fired Liddell plant

* No formal offer received - AGL * Liddell slated to be closed in 2022 * Australia government sought Alinta's interest (Adds fresh Alinta MD quote, April 4 -

ANGLE Shares Rise As Pelvic Mass Test Scores High Prediction Rate

LONDON (Alliance News) - Liquid biopsy firm ANGLE PLC shares climbed on Monday as it said results from a study into is pelvic mass triage test showed a high proportion of were

EUROPE RESEARCH ROUNDUP-Capital & Counties Properties, Inmarsat, Norsk Hydro

March 13 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Capital & Counties Properties, Inmarsat and Norsk Hydro, on Tuesday. * :

Private equity OpCapita buys owner of Rossopomodoro pizza chain

MILAN, March 9 (Reuters) - European private equity firm OpCapita said on Friday it had reached a deal to buy the majority of Sebeto, an Italian restaurant group whose pizza at

Angle selected for European cancer ID programme

(ShareCast News) - Medical technology company Angle has been chosen to take part in Cancer-ID, a European consortium to validate blood-based biomarkers for cancer, by providing a number of Parsortix instruments and associated consumables for evaluation. The evaluation phase, which runs until 2020, w

Angle Sees Positive Interim Evaluation In Ovarian Cancer Studies

Angle Welcomes Supportive Research On Using Parsortix System

UK Earnings, Trading Statements Calendar - Next 7 Days

Angle initiates 200 patient European ovarian cancer study

(ShareCast News) - Medical technology company Angle's European ovarian cancer study has been formally initiated with a first patient recruited. Angle completed the process required to initiate this study, which included optimising the system protocols for the application, development and approval of

Angle Recruits First Patient For European Ovarian Cancer Study

ANGLE Flags Parsortix System Traction At Manchester Conference

Sunday share tips: Purplebricks, Associated British Foods, Angle

(ShareCast News) - Purplebricks Group shares were a 'buy' in the Sunday Times' Inside the City column. Investing in this online estate agency might be a wild ride, with the shares trading for more than 40 times earnings, but some notable names are on the register since its IPO at the end of last yea

ANGLE Signs University Of Manchester Deal, Raises GBP10.2 Million (ALLISS)